NEW YORK ( TheStreet) -- Alexion Pharmaceuticals (Nasdaq: ALXN) hit a new 52-week high Tuesday as it is currently trading at $89.94, above its previous 52-week high of $89.90 with 1.3 million shares traded as of 3:35 p.m. ET. Average volume has been 1.2 million shares over the past 30 days. Alexion has a market cap of $13.68 billion and is part of the health care sector and drugs industry. Shares are up 25.6% year to date as of the close of trading on Monday. Alexion Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of biologic therapeutic products in the United States, Europe, Latin America, Japan, and the Asia Pacific. The company has a P/E ratio of 97.8, above the average drugs industry P/E ratio of 92.5 and above the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter